This grant, offered by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), is for eligible United States small businesses. It invites applications for Small Business Innovation Research (SBIR) projects. US small businesses with research capabilities and technological expertise relevant to the R&D missions of NIH and CDC awarding components are encouraged to apply. A central requirement for this funding opportunity is that the proposed project must include at least one clinical trial. All projects must align with the programmatic interests and scientific missions of one or more participating NIH Institutes and Centers, fostering innovation in critical public health areas.
Opportunity ID: 340861
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-22-177 |
Funding Opportunity Title: | PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Environment Food and Nutrition Health Income Security and Social Services |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.068 — Chronic Diseases: Research, Control, and Prevention |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jun 02, 2022 |
Last Updated Date: | Jun 02, 2022 |
Original Closing Date for Applications: | Apr 05, 2023 |
Current Closing Date for Applications: | Apr 05, 2023 |
Archive Date: | May 11, 2023 |
Estimated Total Program Funding: | – |
Award Ceiling: | $275,766 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH and CDC awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-22-177.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 340861 Full Announcement-PA-22-177 -> PA-22-177-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or before January 24, 2023 | PKG00274778 | Aug 05, 2022 | Jan 24, 2023 | View | |
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277442 | Oct 26, 2022 | Apr 05, 2023 | View |
Package 1
Mandatory forms
340861 RR_SF424_5_0-5.0.pdf
340861 PHS398_CoverPageSupplement_5_0-5.0.pdf
340861 RR_OtherProjectInfo_1_4-1.4.pdf
340861 PerformanceSite_4_0-4.0.pdf
340861 RR_KeyPersonExpanded_4_0-4.0.pdf
340861 RR_Budget_3_0-3.0.pdf
340861 PHS398_ResearchPlan_4_0-4.0.pdf
340861 SBIR_STTR_Information_3_0-3.0.pdf
340861 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
340861 RR_SubawardBudget30_3_0-3.0.pdf
340861 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
340861 RR_SF424_5_0-5.0.pdf
340861 PHS398_CoverPageSupplement_5_0-5.0.pdf
340861 RR_OtherProjectInfo_1_4-1.4.pdf
340861 PerformanceSite_4_0-4.0.pdf
340861 RR_KeyPersonExpanded_4_0-4.0.pdf
340861 RR_Budget_3_0-3.0.pdf
340861 PHS398_ResearchPlan_5_0-5.0.pdf
340861 SBIR_STTR_Information_3_0-3.0.pdf
340861 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
340861 RR_SubawardBudget30_3_0-3.0.pdf
340861 PHS_AssignmentRequestForm_3_0-3.0.pdf